CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 12,000 shares (option exercise)
- 4 Open-market sale Director sold 9,000 shares at $1.95 ($17,550)
- 4 Option exercise Director acquired 18,000 shares (option exercise)
- 4 Open-market sale Director sold 3,600 shares at $1.98 ($7,128)
- 4 Option exercise Director acquired 18,000 shares (option exercise)
- 4 Option exercise Director acquired 18,000 shares (option exercise)
- 4 Option exercise Director acquired 18,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Operating Officer gave up 7,247 shares (to pay taxes)
- 4 Option exercise Director acquired 4,273 shares (option exercise)
- 4 Open-market sale Director sold 2,000 shares at $3.16 ($6,320)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 20,658 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 20,658 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 25,974 shares (to pay taxes)
- 4 Open-market sale Director sold 4,083 shares at $3.20 ($13,066)
- 4 Shares withheld for taxes Chief Executive Officer gave up 39,698 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 31,410 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 11,287 shares (to pay taxes)
Page 6 of 30 · 592 filings